Leef Brands (LEEEF) Total Debt (2023 - 2026)

Leef Brands (LEEEF) posted Total Debt of $10.6 million for Q1 2026, down 4.4% sequentially from $11.1 million in Q4 2025.

Leef Brands (LEEEF) Total Debt (2023 - 2026) Analysis & Trends

Leef Brands has reported Total Debt for 4 years, with the latest figure at $10.6 million in Q1 2026.

Quarterly Total Debt changed N/A year-over-year to $10.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.6 million (changed N/A YoY) and the FY2025 annual result came in at $11.1 million, changed 0.37% from the prior year.
Total Debt eased to $10.6 million in Q1 2026 per LEEEF's latest filing, from $11.1 million in the prior quarter.
Over five years, Total Debt peaked at $11.1 million in Q4 2025 and troughed at $8.1 million in Q4 2023.
A 4-year average of $10.2 million and a median of $10.9 million in 2024 frame the typical range for Total Debt.
The sharpest annual moves came in 2024 and 2025: Total Debt jumped 37.47% in 2024, then climbed 0.37% in 2025.
Over 4 years, Total Debt stood at $8.1 million in 2023, then jumped by 37.47% to $11.1 million in 2024, then rose by 0.37% to $11.1 million in 2025, then decreased by 4.4% to $10.6 million in 2026.
According to Business Quant data, Total Debt over the past three periods registered $10.6 million, $11.1 million, and $11.1 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-5.81 Bn
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	16.59 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	9.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	31.47 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	13.35 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	3.92 Bn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	760.00 Mn
10	Leef Brands	59.45 Mn	54.50 Mn	2.41 Mn	10.58 Mn

Download Data